信息搜索
信息关键字:药
 

共有3954条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198]

·聚焦主业夯实核心药品优势佐力药业2020年净利增长逾2倍2021-1-10 18:41:41
·佐力药业年报业绩预增超2倍1.3亿元商誉暗藏危机2021-1-9 12:58:21
·资本市场成推动药物创新重要动力2021-1-9 3:48:45
·资本市场成推动药物创新重要动力2021-1-9 3:19:38
·睿智医药股东上海睿钊质押288万股用于融资2021-1-8 22:54:08
·佐力药业2020年预计净利8500万-9500万主营产品销售增长2021-1-8 22:29:13
·华仁药业2020年预计净利9000万-1亿利息费用减少2021-1-8 21:51:30
·尔康制药:为拓展公司市场规模香港尔康拟出资3465万美元设立控股孙公司2021-1-8 21:34:31
·双鹭药业:拟2100万元参与增资新乡双鹭进一步加强其原料药基地建设2021-1-8 21:18:17
·兴齐眼药股东程亚男减持1万股套现约226.7万元2021-1-8 20:40:17
·制度发力中国制药业送走创新成就最大的一年——2020证券时报药物创新年度报告2021-1-8 18:53:00
·为何济民制药股价崩盘十跌停 济民制药怎么了?2021-1-8 12:42:55
·科伦药业净利润预减负债率继续上升重整业绩难2021-1-8 10:15:22
·为何济民制药股价突然跌停 公司收到了监管机构的警示函 2021-1-8 8:46:37
·为何济民制药股价突然跌停 公司收到了监管机构的警示函 2021-1-8 8:21:37
·743家公司预披露2020年业绩医药、新能源汽车、农林牧渔等板块增势喜人2021-1-8 8:08:48
·743家公司预披露A股2020年业绩医药、新能源车、农林牧渔增势喜人2021-1-8 7:52:00
·研究|万年青制药“口袋有钱”反募资补血产销双降募投项目或“放卫星”2021-1-7 23:58:52
·科伦药业2020年预计净利8亿-8.8亿研发投入增加2021-1-7 22:21:49
·徐佳熹:医药行业分化加剧投资聚焦龙头2021-1-7 22:13:25

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198]